Aaron G.L. Fletcher's most recent trade in Cognition Therapeutics Inc was a trade of 7,729 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2025 | 7,729 | 0 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 19 Sep 2025 | 7,729 | 56,229 | - | 0.8 | 6,492 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Jun 2025 | 71,428 | 71,428 | - | - | Warrant (Right to Buy) | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 27 Jun 2025 | 71,428 | 196,428 | - | 7 | 499,996 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 34,000 | 48,500 | - | 0 | Common Stock | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 15,000 | 15,000 | - | - | Stock Options | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,094,650 | 2,094,650 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,094,650 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,022,029 | 2,022,029 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,022,029 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 884,427 | 884,427 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 884,427 | 0 | - | - | Convertible Note | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 573,394 | 573,394 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 573,394 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 525,797 | 525,797 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 525,797 | 0 | - | - | Series A Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 484,638 | 2,506,667 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 484,638 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 462,073 | 462,073 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 462,073 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Aug 2024 | 375,000 | 1,259,427 | - | 8 | 3,000,000 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 332,867 | 971,439 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 332,867 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 326,547 | 326,547 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 326,547 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 309,589 | 309,589 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 309,589 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 307,538 | 307,538 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 307,538 | 0 | - | - | Series A Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 176,499 | 638,572 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 176,499 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 153,702 | 153,702 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 153,702 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 147,047 | 300,749 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 147,047 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 141,457 | 141,457 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 141,457 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Aug 2024 | 125,000 | 125,000 | - | 8 | 1,000,000 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 101,900 | 297,389 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 101,900 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 78,267 | 404,814 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 78,267 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 74,202 | 383,791 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 74,202 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 61,857 | 61,857 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 61,857 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 54,032 | 195,489 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 54,032 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 44,559 | 130,044 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 44,559 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 26,355 | 997,794 | - | 5.3 | 138,891 | Common Stock | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 26,355 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 23,628 | 85,485 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 23,628 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 17,361 | 980,433 | - | 9 | 156,249 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 17,361 | 980,433 | - | 8 | 138,888 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 15,000 | 15,000 | - | - | Stock Options | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 8,068 | 305,457 | - | 5.3 | 42,518 | Common Stock | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 8,068 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 5,314 | 300,143 | - | 9 | 47,826 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 5,314 | 300,143 | - | 8 | 42,512 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 3,528 | 133,572 | - | 5.3 | 18,593 | Common Stock | |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 3,528 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 2,324 | 131,248 | - | 9 | 20,916 | Common Stock |
| Actuate Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 2,324 | 131,248 | - | 8 | 18,592 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 8,500 | 14,500 | - | 0 | Common Stock | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 6,000 | 6,000 | - | 0 | Common Stock | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 12,220 | 2,021,906 | - | 2.6 | 32,379 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 1,973 | 326,733 | - | 2.6 | 5,228 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 1,871 | 309,748 | - | 2.6 | 4,958 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 22 Nov 2022 | 43,470 | 143,470 (0%) | 0% | 1.2 | 49,991 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2022 | 21,735 | 21,735 | - | - | Common Stock Purchase Warrants | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 54,009 | 2,009,686 | - | 1.4 | 75,613 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 8,722 | 324,760 | - | 1.4 | 12,211 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 8,269 | 307,877 | - | 1.4 | 11,577 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 1,141,030 | 1,955,677 | - | 1.2 | 1,369,236 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 184,270 | 316,038 | - | 1.2 | 221,124 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 174,700 | 299,608 | - | 1.2 | 209,640 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 8,335 | 11,054 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 8,335 | 11,054 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 8,585 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 3,614 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 3,614 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 8,585 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 23 May 2022 | 150,000 | 885,000 (3%) | 0% | 3.5 | 528,000 | Common Stock |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 23 May 2022 | 55,000 | 940,000 (4%) | 0% | 3.3 | 183,700 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 16 May 2022 | 85,000 | 85,000 (0%) | 0% | 4.9 | 413,100 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 16 May 2022 | 24,600 | 109,600 (0%) | 0% | 5.1 | 124,968 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 04 Apr 2022 | 500,000 | 500,000 (2%) | 2% | 6.4 | 3,215,000 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 6.89 per share. | 04 Apr 2022 | 42,000 | 542,000 (2%) | 0% | 6.9 | 289,380 | Common Stock |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 31 Mar 2022 | 735,000 | 735,000 (3%) | 3% | 4.8 | 3,498,600 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Jan 2022 | 1,145 | 1,145 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Jan 2022 | 1,145 | 2,719 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Swk Holdings Corp | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 250 | 9,373 (0%) | 0% | - | Common Stock | |
| Swk Holdings Corp | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 250 | 9,123 (0%) | 0% | - | Common Stock | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |